Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05025345 · ClinicalTrials.gov registry record · NA

Vision Performance Evaluation of TECNIS EYHANCE™ With TECNIS SIMPLICITY™ Compared to TECNIS® 1-piece Intraocular Lenses

A NA study, sponsored by Johnson & Johnson Surgical Vision.

Completed
Registry status
NA
Development phase
228
Enrollment target

NCT05025345: Completed NA study, sponsored by Johnson & Johnson Surgical Vision.

NCT05025345 is a NA study that has completed, run by Johnson & Johnson Surgical Vision. The registered enrollment target is 228 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05025345, a NA study, has completed, sponsored by Johnson & Johnson Surgical Vision.

COMPLETED
Registry status
NA
Development phase
228 participants
Enrollment target

Study Summary

This study is a 6-month, prospective, multicenter, bilateral, randomized subject- and evaluator-masked, clinical investigation of the TECNIS Eyhance IOL versus the TECNIS 1-piece IOL. The study will be conducted at up to 15 sites in the U.S.A and will enroll approximately 220 subjects to achieve approximately 200 randomized and bilaterally implanted subjects, resulting in approximately 100 evaluable subjects in each lens group at 6 months. Subjects are to be implanted with the same IOL in both eyes: TECNIS Eyhance IOL or the TECNIS 1-Piece IOL. The eye implanted first will be considered the primary study eye.

Primary Outcome

the mean monocular difference in Best-Corrected Distance Visual Acuity for the first eye between lens groups

Interventions

  • DEVICE Tecnis Eyhance
  • DEVICE Tecnis 1 piece IOL

Trial Details

FieldValue
Enrollment Target 228 participants
Start Date 2021-09-02
Est. Completion 2022-06-17
Phase NA
Johnson & Johnson Surgical Vision

22 total trials

What the finished NCT05025345 record still lists

NCT05025345 is an interventional study that assigns participants to a tested intervention. The registered 228 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).

The record links to 0 conditions, and to 2 interventions - of which Tecnis Eyhance is the first listed.

NCT05025345 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05025345 about?

NCT05025345 is a clinical study titled "Vision Performance Evaluation of TECNIS EYHANCE™ With TECNIS SIMPLICITY™ Compared to TECNIS® 1-piece Intraocular Lenses". This study is a 6-month, prospective, multicenter, bilateral, randomized subject- and evaluator-masked, clinical investigation of the TECNIS Eyhance IOL versus the TECNIS 1-piece IOL. The study will be conducted at up to 15 sites in the U.S.A and will enroll approximately 220 subjects to achieve ap...

What is the current status of trial NCT05025345?

This trial is currently completed. It is a NA study. The enrollment target is 228 participants. The study started on 2021-09-02. Estimated completion is 2022-06-17.

What interventions are being tested in trial NCT05025345?

The interventions under investigation include: Tecnis Eyhance (DEVICE), Tecnis 1 piece IOL (DEVICE).

Who is sponsoring clinical trial NCT05025345?

This trial is sponsored by Johnson & Johnson Surgical Vision, which has 22 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05025345's enrollment target sits among peer trials

228 468th of 2000 higher than 1,530 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05107908 · 228 participants · NA

    Neuronal and Behavioral Effects of an Implicit Priming Approach to Improve Eating Behaviors in Obesity

  • NCT05547698 · 228 participants · NA

    A Study of Venoarterial ECMO vs Off-Pump Bilateral Orthotopic Lung Transplantation

  • NCT05630963 · 228 participants

    Beyond Monoamines: The Role of the Nociceptin/Orphanin FQ Receptor in Major Depression

  • NCT06073665 · 228 participants · Phase 4

    Dosing of LT4 in Older Individuals

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05025345, the US trial registry maintained by the National Library of Medicine. NCT05025345 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.